Hitoshi Funabashi
Impact in
-
- Effects and risks of endocrine disrupting chemicals
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
- Pluripotent Stem Cells Research 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Takeshi Kunimatsu (10 shared papers)Juki Kimura (12 shared papers)Takaki Seki (9 shared papers)Kiyoko Bando (3 shared papers)Izuru Miyawaki (9 shared papers)Jun Sakai (2 shared papers)Takeshi Bamba (2 shared papers)Eiichiro Fukusaki (2 shared papers)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Regulatory Toxicology and Pharmacology (3 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2 papers)Toxicologic Pathology (1 paper)Toxicology Letters (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hitoshi Funabashi
27 papers receiving 583 citations
Peers
Comparison fields: 5 of 92
- Health, Toxicology and Mutagenesis 83
- Pharmacology 45
- Molecular Biology 255
- Small Animals 22
- Cancer Research 38
Countries citing papers authored by Hitoshi Funabashi
This map shows the geographic impact of Hitoshi Funabashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Funabashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Funabashi more than expected).
Fields of papers citing papers by Hitoshi Funabashi
This network shows the impact of papers produced by Hitoshi Funabashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Funabashi. The network helps show where Hitoshi Funabashi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hitoshi Funabashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. | 2001 | 123 |
| 2 | 2010 | 86 | |
| 3 | 2012 | 56 | |
| 4 | 2010 | 49 | |
| 5 | 2014 | 44 | |
| 6 | 2014 | 35 | |
| 7 | 2003 | 28 | |
| 8 | 2010 | 24 | |
| 9 | 2010 | 24 | |
| 10 | 2014 | 23 | |
| 11 | 2015 | 15 | |
| 12 | 2000 | 14 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 9 | |
| 15 | 2015 | 8 | |
| 16 | 2012 | 8 | |
| 17 | 2015 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2011 | 4 | |
| 20 | 2013 | 4 |
About Hitoshi Funabashi
Hitoshi Funabashi is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 28 papers that have together received 594 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Neuroscience and Neural Engineering (3 papers), Pluripotent Stem Cells Research (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (83 citations), Pharmacology (45 citations), Molecular Biology (255 citations), Small Animals (22 citations) and Cancer Research (38 citations). Hitoshi Funabashi has collaborated with scholars based in Japan and United States. Frequent co-authors include Takeshi Kunimatsu, Juki Kimura, Takaki Seki, Kiyoko Bando, Izuru Miyawaki, Jun Sakai, Takeshi Bamba, Eiichiro Fukusaki, Hiroshi Inada and Masaharu Onoue. Their work appears in journals such as Toxicology and Applied Pharmacology, Regulatory Toxicology and Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Toxicologic Pathology and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.